statistiche ricercatore

Continente	#
NA - Nord America	2.003
AS - Asia	892
EU - Europa	635
SA - Sud America	121
Continente sconosciuto - Info sul continente non disponibili	45
AF - Africa	12
OC - Oceania	2
Totale	3.710

Nazione	#
US - Stati Uniti d'America	1.959
SG - Singapore	314
CN - Cina	203
GB - Regno Unito	201
VN - Vietnam	115
IT - Italia	100
BR - Brasile	87
HK - Hong Kong	87
SE - Svezia	72
FR - Francia	56
DE - Germania	49
FI - Finlandia	41
RU - Federazione Russa	41
TR - Turchia	34
UA - Ucraina	31
BD - Bangladesh	30
IN - India	28
CA - Canada	26
KR - Corea	17
ID - Indonesia	14
BG - Bulgaria	12
MX - Messico	12
AR - Argentina	9
IQ - Iraq	9
JP - Giappone	7
PL - Polonia	7
VE - Venezuela	7
CL - Cile	5
ES - Italia	5
PK - Pakistan	5
SA - Arabia Saudita	5
CO - Colombia	4
EC - Ecuador	4
IE - Irlanda	4
NL - Olanda	4
AZ - Azerbaigian	3
CZ - Repubblica Ceca	3
TW - Taiwan	3
AL - Albania	2
DZ - Algeria	2
EG - Egitto	2
IR - Iran	2
JM - Giamaica	2
KG - Kirghizistan	2
LV - Lettonia	2
NP - Nepal	2
PY - Paraguay	2
TN - Tunisia	2
UZ - Uzbekistan	2
ZA - Sudafrica	2
A2 - ???statistics.table.value.countryCode.A2???	1
AE - Emirati Arabi Uniti	1
AT - Austria	1
AU - Australia	1
BE - Belgio	1
BH - Bahrain	1
BN - Brunei Darussalam	1
BZ - Belize	1
CR - Costa Rica	1
CV - Capo Verde	1
DK - Danimarca	1
ET - Etiopia	1
EU - Europa	1
GF - Guiana Francese	1
GT - Guatemala	1
JO - Giordania	1
KE - Kenya	1
KZ - Kazakistan	1
LB - Libano	1
LT - Lituania	1
MA - Marocco	1
ME - Montenegro	1
MN - Mongolia	1
NI - Nicaragua	1
NZ - Nuova Zelanda	1
OM - Oman	1
PE - Perù	1
PH - Filippine	1
PS - Palestinian Territory	1
UY - Uruguay	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	3.668

Nome	#
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease	430
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments	368
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study	330
Novel drug targets for idiopathic pulmonary fibrosis	304
Pulmonary fibrosis and the many faces of UIP	297
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy	295
Management of Idiopathic Pulmonary Fibrosis	295
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report	291
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease	254
Challenges in idiopathic interstitial lung disease	241
Long-term management of IPF with pirfenidone - A clinical case study with 5 years follow-up	199
Automated system for diagnosing pulmonary fibrosis using crackle analysis in recorded lung sounds based on iterative envelope mean fractal dimension filter	148
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study	125
Efectiveness of Nintedanib in Progressive Pulmonary Fibrosis Assessed by Progression Criteria: An Italian, Observational, Multicenter Study	116
Multidisciplinary management of interstitial lung disease in autoimmune rheumatic diseases: an Italian Delphi consensus	17
Totale	3.710

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	193	0	0	4	21	8	19	5	11	24	19	56	26
2022/2023	252	28	39	17	32	22	38	2	18	31	2	5	18
2023/2024	165	4	9	9	25	28	23	9	19	7	3	11	18
2024/2025	535	17	9	11	27	93	74	48	48	61	15	55	77
2025/2026	1.230	84	64	87	141	196	82	169	56	132	109	76	34
2026/2027	132	40	86	6	0	0	0	0	0	0	0	0	0
Totale													3.710